Skip to main content

iDR25 Conference Hub

MEDICINES REIMAGINED: UNLOCKING THE POTENTIAL OF EXISTING DRUGS FOR PATIENT BENEFIT

Over 300 participants gathered in Amsterdam on 7–8 May 2025 for the second edition of the International Drug Repurposing (iDR) Conference. Attendees included leading figures from the research and patient communities, regulatory and HTA bodies, health authorities, and the pharmaceutical and generics industries.

This year’s conference focused on artificial intelligence, innovative clinical trial designs, drug repurposing for underserved populations, and pathways to patient access. The event highlighted the transformative potential of drug repurposing, fostering collaboration and innovation across sectors and borders.

Photo gallery

All conference photos

iDR25 Articles

View highlights from

iDR25 

Take a look at the key moments of the conference.

Play Video

Insights from iDR25 Speakers

Listen to some of our key speakers of the 2024 event and their insights on the importance of the iDR Conference Series.

Play Video

iDR25 Resources

Explore the collection of iDR25 resources available.

Conference programme

The full programme of iDR25

Session recondings and presentations

Only available to iDR25 attendees

Delegate list

Only available to iDR25 attendees

Posters

The iDR25 digital poster pack

iDR25 Testimonials

What attendees say about the conference

“

Every session had value, every speaker came with powerful insights that moved the needle in my understanding of the drug repurposing space, and informed how I will move my organization forward.

“

This conference really gave me hope and ideas how to move forward as a parent organization to start research into treatment for our children.

“

As someone who is simultaneously a patient, physician, and researcher, I found it profoundly valuable and meaningful to see the multifaceted dimensions of drug repurposing so thoughtfully highlighted and seamlessly integrated throughout the conference.

“

iDR25 was the biggest international event EVER bringing together all relevant players that are currently moving the needle in drug repurposing.

“

iDR25 was a great meeting. To hear the patient and caretakers voices allows industry to tailor solutions accordingly.

“

Engaging and energising conference with a sense of community purpose to look at progression of drug repurposing.

Co-organisers

REMEDi4ALL

REMEDi4ALL is an EU-funded research initiative that is driving forward the repurposing of medicines in Europe.

Link to website
Beacon: For Rare Diseases (BEACON) - United Kingdom
Beacon for rare diseases

Beacon is a UK-based charity that is building a united rare disease community with patient groups at its heart.

Link to website

Sponsors

ZONMW

ZonMw is the Dutch governmental organisation which programmes and funds research and innovation in health, healthcare, and well-being, encourages the use of this knowledge and highlights knowledge needs. ZonMw has been funding Drug Repurposing research for more than 10 years and has a dedicated funding call for Drug Repurposing.

Link to website
CHAN ZUCKERBERG INITIATIVE

The Chan Zuckerberg Initiative was founded in 2015 to help solve some of society’s toughest challenges — from eradicating disease and improving education, to addressing the needs of our local communities. Our mission is to build a better future for everyone.

Link to website
DOMPÉ FARMACEUTICI S.P.A.

Dompé Farmaceutici S.p.A. is an international biopharmaceutical company involved in all activities of the pharmaceutical value chain, from research to development, production and marketing. Our evolution has taken us from being Milan’s first compounding pharmacy to an international company that straddles both primary care and biopharma.

Link to website
LIFEARC

LifeArc is a not-for-profit medical research organisation; we turn promising scientific research into impact for people living with rare diseases and areas of global health.

Link to website
Close Menu